FDA Drug recall D-0065-2025
THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-0…
- FDA Drug
- Class II
- terminated
- Published 2024-12-04
On 2024-12-04 the FDA classified a Class II recall of THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-0… by Unexo Life Sciences Private, citing cGMP Deviations.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0065-2025 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2024-10-24 |
| Published | 2024-12-04 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Unexo Life Sciences Private |
| Distribution | US |
Product
THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6), Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031
Reason
cGMP Deviations
Identifiers
| upc | 845717008785 |
|---|---|
| upc | 845717010566 |
| ndc | 71101-001-06 |
| ndc | 71101-001-24 |
| code_info | a) UPC 8 45717 00878 5 b) UPC 8 45717 01056 6 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0065-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.